- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03375840
Pictorial Warning Labels and Memory for Cigarette Health-risk Information Over Time
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 19-65 years old (adult samples)
- have smoked 100+ lifetime cigarettes (adult samples)
- currently smoke "every day" or "some days." (adult samples)
- 14-18 years old (teen sample)
- have ever smoked a cigarette (teen sample)
Exclusion Criteria:
• have not ever smoked a cigarette (all samples)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Text-only PWL, immediate post
Exposure to 9 FDA-mandated warning labels Posttest measures (e.g., memory, risk perceptions, quit intentions) administered immediately following last exposure to warning labels |
Control condition
|
Experimental: Text-only PWL, delay posttest
Exposure to 9 FDA-mandated warning labels Posttest measures (e.g., memory, risk perceptions, quit intentions) administered 6 weeks after last exposure to warning labels |
Control condition
|
Experimental: Low-emot PWL, immediate posttest
Exposure to 9 warning labels paired with image that elicited little emotion Posttest measures (e.g., memory, risk perceptions, quit intentions) administered immediately following last exposure to warning labels |
Pictorial warning
|
Experimental: Low-emot PWL, delay posttest
Exposure to 9 warning labels paired with image that elicited little emotion Posttest measures (e.g., memory, risk perceptions, quit intentions) administered 6 weeks after last exposure to warning labels |
Pictorial warning
|
Experimental: High-emot PWL, immediate posttest
Exposure to 9 warning labels paired with image that elicited high emotion Posttest measures (e.g., memory, risk perceptions, quit intentions) administered immediately following last exposure to warning labels |
Pictorial warning
|
Experimental: High-emot PWL, delay posttest
Exposure to 9 warning labels paired with image that elicited high emotion Posttest measures (e.g., memory, risk perceptions, quit intentions) administered 6 weeks after last exposure to warning labels |
Pictorial warning
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
graphic warning label recall
Time Frame: immediately following last exposure or after 6-week delay
|
free recall for risk information presented in labels (9 text boxes, 1 for each label; coded for exact or equivalent words)
|
immediately following last exposure or after 6-week delay
|
smoking risk recognition
Time Frame: immediately following last exposure or after 6-week delay
|
Participants were subsequently shown twenty-six negative health effects and asked "Which of the following health effects were mentioned in the warnings we showed you?" and responded "Yes, I saw this health effect" or "No, I did not see this health effect."
Fourteen risks were mentioned in the warnings (e.g., cancer, harms children, emphysema); six were risks of smoking not presented in the warnings (e.g., wrinkles, diabetes), and six were not risks of smoking (e.g., acne, thyroid problems).
|
immediately following last exposure or after 6-week delay
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
smoking risk perceptions
Time Frame: immediately following last exposure or after 6-week delay
|
participants completed several scale items about how much risk they perceived smoking posed to them (e.g., "Compared to the average nonsmoker your age, gender, and race, how would you rate your chances of": 1) "getting a life threatening illness because of smoking," 2) "getting lung cancer," and 3) "dying at a younger age than average" (-3 = Much lower, +3 = Much higher))
|
immediately following last exposure or after 6-week delay
|
quit intentions
Time Frame: immediately following last exposure or after 6-week delay
|
participants' intentions to quit smoking
|
immediately following last exposure or after 6-week delay
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- P50CA180908A1
- P50CA180908 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
Yale UniversityCompletedSmoking | Smoking CessationUnited States
-
Johns Hopkins UniversityMaryland Department of Health and Mental HygieneCompletedCOach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation (C2Q)Smoking | Smoking CessationUnited States
Clinical Trials on Text-only PWL
-
Ohio State UniversityUniversity of PennsylvaniaCompletedSmoking Cessation | Smoking, Cigarette
-
Ohio State UniversityUniversity of PennsylvaniaCompletedSmoking Cessation | Smoking, Cigarette
-
Ohio State UniversityUniversity of PennsylvaniaCompletedSmoking Cessation | Smoking, CigaretteUnited States
-
Duke UniversityCompleted
-
Stanford UniversityHarvard Pilgrim Health CareCompleted
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); University of California, Davis; University... and other collaboratorsActive, not recruitingEducational ActivitiesUnited States
-
Boston UniversityNational Cancer Institute (NCI); Brown University; National Institutes of Health... and other collaboratorsCompleted
-
University of PittsburghCompleted
-
University of CincinnatiFoundation for Informed Medical Decision MakingCompletedCoronary Artery DiseaseUnited States
-
University of PennsylvaniaCompleted